KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $455.3 million.

  • Cme's Dividends Paid - Common rose 879.33% to $455.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 billion, marking a year-over-year increase of 929.18%. This contributed to the annual value of $3.6 billion for FY2024, which is 1077.73% up from last year.
  • Latest data reveals that Cme reported Dividends Paid - Common of $455.3 million as of Q3 2025, which was up 879.33% from $455.3 million recorded in Q2 2025.
  • Cme's Dividends Paid - Common's 5-year high stood at $2.6 billion during Q1 2025, with a 5-year trough of $322.5 million in Q2 2021.
  • In the last 5 years, Cme's Dividends Paid - Common had a median value of $418.5 million in 2024 and averaged $795.8 million.
  • In the last 5 years, Cme's Dividends Paid - Common skyrocketed by 166.17% in 2021 and then soared by 3188.21% in 2023.
  • Cme's Dividends Paid - Common (Quarter) stood at $326.8 million in 2021, then increased by 11.23% to $363.5 million in 2022, then grew by 10.07% to $400.1 million in 2023, then rose by 4.67% to $418.8 million in 2024, then grew by 8.72% to $455.3 million in 2025.
  • Its last three reported values are $455.3 million in Q3 2025, $455.3 million for Q2 2025, and $2.6 billion during Q1 2025.